CalciMedica
CALC
24 hedge funds and large institutions have $10.2M invested in CalciMedica in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 3 closing their positions.
2,840% more call options, than puts
Call options by funds: $147K | Put options by funds: $5K
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
4% less funds holding
Funds holding: 25 → 24 (-1)
13% less capital invested
Capital invested by funds: $11.7M → $10.2M (-$1.53M)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$150K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$52.6K |
| 3 |
Jane Street
New York
|
+$11.6K |
| 4 |
Morgan Stanley
New York
|
+$3.04K |
| 5 |
Brown Advisory
Baltimore,
Maryland
|
+$1.27K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$50.6K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$34.3K |
| 3 |
Two Sigma Investments
New York
|
-$19K |
| 4 |
LCS
Levin Capital Strategies
New York
|
-$16K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$15.9K |
CALC Hedge Fund Activity: Q3 2022 in Review
24 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in CalciMedica (CALC) for Q3 2022, worth a combined $10.2M — down 13% from $11.7M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of CALC and 2 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 5 added.
The largest buyer was Renaissance Technologies, adding an estimated $150K. The largest seller was Bridgeway Capital Management, cutting an estimated $50.6K.
- 24 institutional investors held CalciMedica (CALC) as of Q3 2022, down from 25 in Q2 2022.
- Funds reported $10.2M of CalciMedica stock for Q3 2022, down 13% quarter-over-quarter.
- 2 funds opened new CalciMedica positions in Q3 2022 and 3 closed out, a net change of -1 holder.
- The largest CalciMedica buyer in Q3 2022 was Renaissance Technologies, an estimated $150K added.
- The largest CalciMedica seller in Q3 2022 was Bridgeway Capital Management, an estimated $50.6K sold.
Based on aggregated 13F filings for Q3 2022.